Replacement of dilation and curettage/evacuation by manual vacuum aspiration and medical abortion, and the introduction of postabortion contraception in Pakistan

Int J Gynaecol Obstet. 2014 Jul:126 Suppl 1:S40-4. doi: 10.1016/j.ijgo.2014.03.016. Epub 2014 Mar 30.

Abstract

Manual vacuum aspiration (MVA) and medical abortion were introduced to replace dilation and curettage/evacuation for incomplete abortions, and postabortion contraception was provided in 5 selected public hospitals in Pakistan. In the largest hospital, an Ipas MVA training center since 2007, MVA use reached 21% in 2008. After the International Federation of Gynecology and Obstetrics (FIGO) and UNFPA provided MVA kits, MVA use increased dramatically to 70%-90% in 2010-2013. In 2 of the remaining 4 hospitals in which the Society of Obstetricians and Gynecologists of Pakistan trained doctors in May 2012 and January 2013, the target of having 50% of women managed by MVA and medical abortion (MA) was met; however, in the third hospital only 43% were treated with MVA and MA. In the fourth hospital, where misoprostol and electric vacuum aspiration use was 64% and 9%, respectively, before training, an MVA workshop introduced the technique. Postabortion contraception was provided to 9%-29% of women, far below the target of 60%.

Keywords: Dilation and curettage; FIGO initiative; Manual vacuum aspiration; Medical abortion; Pakistan; Postabortion contraception; Prevention; Unsafe abortion.

MeSH terms

  • Abortifacient Agents, Nonsteroidal / administration & dosage*
  • Abortion, Incomplete / therapy*
  • Aftercare / methods
  • Contraception / methods
  • Dilatation and Curettage / methods
  • Dilatation and Curettage / statistics & numerical data
  • Female
  • Gynecology / organization & administration
  • Hospitals, Public
  • Humans
  • Misoprostol / administration & dosage*
  • Obstetrics / organization & administration
  • Pakistan
  • Pregnancy
  • Societies, Medical / organization & administration
  • Vacuum Curettage / methods*
  • Vacuum Curettage / statistics & numerical data

Substances

  • Abortifacient Agents, Nonsteroidal
  • Misoprostol